The stock can still compound well, but it already discounts a lot of future success. The path to upside is becoming a broader space platform with more recurring, higher-value revenue from communications, mission operations, and integrated programs, not simply doing more launches. If Rocket Lab proves
Neutron, absorbs Iridium, and keeps winning bundled defense and constellation work, the business can grow into the valuation and still
re-rate moderately.